Rabies

Cost-Effective Regimens Offer Similar Protection

Published in Vaccine Weekly, September 12th, 2001

by N.R. Saltmarsh, staff medical writer - Two postexposure rabies vaccine regimens recommended by the World Health Organization (WHO) appear to have similar protective efficacy in an Indian population with mild exposure to the disease.

Further evaluation is needed in the field, but the intradermal vaccines appear to offer a cost-effective alternative to intramuscular injection, which may make them ideal for use in developing countries, said S.N. Madhusudana and colleagues at the National Institute for Mental Health and Neuroscience, Karnataka.

"The World Health Organization has advocated two cost-effective intradermal regimens with cell culture...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-09-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry